Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Omni Inovasi Indonesia Tbk. (TELE)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Omni Inovasi Indonesia Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Omni Inovasi Indonesia Tbk. diperdagangkan di Rp9 (kapitalisasi pasar 65,8 M). Perbedaan utamanya: Organon Pharma Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | TELE | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 65,8 M |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Omni Inovasi Indonesia Tbk.
PT Tiphone Mobile Indonesia Tbk (the Company) established based on Notarial Deed No. 62 dated June 25, 2008 of David, S.H. Tiphone or Ti-Phone is a mobile phone brand owned by PT Tiphone Mobile Indonesia, which is a sister company of PT Telesindo Shop, a cell phone chain store and distributor.
Selengkapnya di halaman TELE →
